Fig. 1From: A prospective trial to evaluate the clinical efficacy and safety of neoadjuvant chemotherapy with arsenic trioxide and carboplatin in locally advanced cervical cancer: a study protocol for randomized controlled clinicalFlow chart of the study. RECIST, Response Evaluation Criteria in Solid Tumors (version 1.1); CTCAE, Common Terminology Criteria for Adverse Events (version 4.03)Back to article page